Concord Wealth Partners’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.3K | Buy |
763
+100
| +15% | +$3.84K | ﹤0.01% | 412 |
|
|
2025
Q1 | $25.7K | Sell |
663
-74
| -10% | -$2.87K | ﹤0.01% | 406 |
|
|
2024
Q4 | $24.9K | Sell |
737
-46
| -6% | -$1.56K | ﹤0.01% | 425 |
|
|
2024
Q3 | $32K | Buy |
783
+547
| +232% | +$22.4K | 0.01% | 399 |
|
|
2024
Q2 | $9.09K | Sell |
236
-1,200
| -84% | -$46.2K | ﹤0.01% | 519 |
|
|
2024
Q1 | $61.6K | Buy |
1,436
+590
| +70% | +$25.3K | 0.01% | 322 |
|
|
2023
Q4 | $31.4K | Sell |
846
-1,499
| -64% | -$55.6K | 0.01% | 425 |
|
|
2023
Q3 | $85K | Buy |
2,345
+1,142
| +95% | +$41.4K | 0.02% | 304 |
|
|
2023
Q2 | $42.9K | Buy |
1,203
+40
| +3% | +$1.43K | 0.01% | 388 |
|
|
2023
Q1 | $41.4K | Sell |
1,163
-130
| -10% | -$4.63K | 0.01% | 375 |
|
|
2022
Q4 | $45.4K | Buy |
+1,293
| New | +$45.4K | 0.01% | 395 |
|
|
2022
Q3 | – | Sell |
-1,268
| Closed | -$69K | – | 551 |
|
|
2022
Q2 | $69K | Sell |
1,268
-1,499
| -54% | -$81.6K | 0.02% | 318 |
|
|
2022
Q1 | $151K | Sell |
2,767
-49
| -2% | -$2.67K | 0.04% | 228 |
|
|
2021
Q4 | $155K | Buy |
2,816
+2,266
| +412% | +$125K | 0.04% | 224 |
|
|
2021
Q3 | $26K | Sell |
550
-1,645
| -75% | -$77.8K | 0.01% | 331 |
|
|
2021
Q2 | $109K | Buy |
2,195
+704
| +47% | +$35K | 0.03% | 222 |
|
|
2021
Q1 | $67K | Buy |
1,491
+855
| +134% | +$38.4K | 0.02% | 286 |
|
|
2020
Q4 | $29K | Buy |
+636
| New | +$29K | 0.02% | 264 |
|